InVivo Therapeutics Holdings Corp. (NASDAQOTH:NVIV)

CAPS Rating: 2 out of 5

Results 1 - 4 of 4

Recs

0
Member Avatar pchop12316 (86.37) Submitted: 9/18/2014 1:16:14 PM : Outperform Start Price: $0.52 NVIV Score: +4.22

should excel

Recs

0
Member Avatar 007mercucio (23.87) Submitted: 9/12/2013 10:37:30 AM : Outperform Start Price: $1.44 NVIV Score: -81.13

cured monkeys of spinal damage induced paralysis - next step, humans
stock at an all time low
heavy accumulation indicates possible buyout target

Recs

0
Member Avatar kentinc (57.16) Submitted: 5/13/2013 2:38:49 PM : Outperform Start Price: $2.94 NVIV Score: -104.35

The big IF is successfully navigating clinical human trials. If it does so then this has massive upside potential.

Recs

0
Member Avatar holytea7 (< 20) Submitted: 3/18/2013 9:45:48 PM : Outperform Start Price: $2.31 NVIV Score: -105.87

Next Top Dog and First Mover in medical device company.

Results 1 - 4 of 4

Featured Broker Partners


Advertisement